Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
Juliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
Archives of Gynecology and Obstetrics
|
December 5, 2020
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Gynecologic Oncology
|
May 9, 2012
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
Werner Meier, Andreas du Bois, Jörn Rau, et al.
Journal of Cancer Research and Clinical Oncology
|
September 6, 2022
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer
Susanne Beyer, Lena Müller, Sophie Mitter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 2, 2020
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
Philipp Harter, Patricia Pautier, Els Van Nieuwenhuysen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study
Alexander Burges, Pauline Wimberger, Carolin Kümper, et al.
Archives of Gynecology and Obstetrics
|
July 21, 2021
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group
Annette Hasenburg, Hellmut Plett, Bernhard Krämer, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
Juliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
Archives of Gynecology and Obstetrics
|
December 5, 2020
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Gynecologic Oncology
|
May 9, 2012
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
Werner Meier, Andreas du Bois, Jörn Rau, et al.
Journal of Cancer Research and Clinical Oncology
|
September 6, 2022
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer
Susanne Beyer, Lena Müller, Sophie Mitter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 2, 2020
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
Philipp Harter, Patricia Pautier, Els Van Nieuwenhuysen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study
Alexander Burges, Pauline Wimberger, Carolin Kümper, et al.
Archives of Gynecology and Obstetrics
|
July 21, 2021
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group
Annette Hasenburg, Hellmut Plett, Bernhard Krämer, et al.
Page
of 12